Form 4: USANA Director Reports Routine Stock Transactions

USANA Health Sciences Director Ding Xia reported the acquisition of 1,057 common shares through RSU vesting and the disposition of 476 shares for tax purposes.

Summary

• Director Ding Xia acquired 1,057 shares of USANA Health Sciences common stock on October 23, 2025, through the vesting and conversion of Restricted Stock Units (RSUs).
• Concurrently, 476 shares of common stock were disposed of on October 23, 2025, at a price of $20.63 per share, likely to cover tax liabilities associated with the RSU vesting.
• Following these transactions, Ding Xia directly holds 5,918 shares of USANA Health Sciences common stock.
• Ding Xia also holds 2,115 Restricted Stock Units after the reported transaction.

Sentiment

Score: 5

Explanation: The filing details a routine insider transaction involving the vesting of equity awards and a tax-related disposition, which is a neutral event in terms of company performance or strategic direction.

Positives

• The vesting of Restricted Stock Units indicates continued equity compensation for the director, aligning their interests with shareholder value.
• The acquisition of common stock through RSU conversion increases the director's direct ownership in the company.

Negatives

• A portion of the acquired shares (476 shares) was immediately disposed of, reducing the net increase in direct ownership, although this is a common practice for tax withholding.

Future Outlook

Remaining Restricted Stock Units are scheduled to vest in two equal tranches of 25% on January 22, 2026, and April 23, 2026.

Industry Context

This filing represents a routine insider transaction related to equity compensation, which is a standard practice across various industries to incentivize and retain key personnel. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The transaction is a routine insider filing and is unlikely to have a significant direct impact on shareholder value or perception. It reflects standard compensation practices for directors.

Next Steps

• Future vesting of remaining Restricted Stock Units on January 22, 2026, and April 23, 2026.

Key Dates

Keywords

USANA Health Sciences, USNA, Form 4, Insider Transaction, Director Stock, Restricted Stock Units, Equity Compensation, Stock Disposition